查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1881808

体外大肠直肠癌筛检市场－全球产业规模、份额、趋势、机会及预测，依检测类型（粪便隐血试验、生物标记检测、CRC DNA筛检检测）、地区和竞争格局划分，2020-2030年预测

In-vitro Colorectal Cancer Screening Tests Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Test Type (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), By Region, Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球体外大肠直肠癌筛检市场规模预计将从2024年的8.9089亿美元成长至2030年的10.6998亿美元，年复合成长率为3.1%。体外大肠直肠癌筛检是指利用粪便或血液等生物样本进行诊断，以检测大肠直肠癌或其癌前病变，从而实现疾病的早期识别，这对于改善治疗效果至关重要。市场成长的主要驱动因素是全球大肠直肠癌发病率的上升以及人们对早期检测方法的日益重视。

市场概览
预测期 2026-2030
2024年市场规模 8.9089亿美元
2030年市场规模 10.6998亿美元
2025-2030年复合年增长率 3.1%
成长最快的细分市场 粪便隐血试验
最大的市场 北美洲

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：客户之声

第五章：全球体外大肠直肠癌筛检检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依检测类型（粪便隐血试验、生物标记检测、CRC DNA筛检检测）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美体外大肠直肠癌筛检试验市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲体外大肠直肠癌筛检试验市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区体外大肠直肠癌筛检试验市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲体外大肠直肠癌筛检市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲体外大肠直肠癌筛检试验市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最新进展

第十三章：全球体外大肠直肠癌筛检市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Eiken Chemical Co., Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quest Diagnostics Incorporated
  • Merck KGaA
  • Kyowa Kirin Co., Ltd.
  • Randox Laboratories Ltd.
  • R-Biopharm AG

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 21803

The Global In-vitro Colorectal Cancer Screening Tests Market will grow from USD 890.89 Million in 2024 to USD 1069.98 Million by 2030 at a 3.1% CAGR. In-vitro colorectal cancer screening tests involve diagnostic procedures utilizing biological samples like stool or blood to detect colorectal cancer or its precursors, thereby enabling early disease identification crucial for improved treatment outcomes. The market's growth is primarily driven by the increasing global prevalence of colorectal cancer and heightened awareness regarding early detection methods.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 890.89 Million
Market Size 2030USD 1069.98 Million
CAGR 2025-20303.1%
Fastest Growing SegmentFecal Occult Blood Tests
Largest MarketNorth America

Key Market Drivers

The escalating global incidence of colorectal cancer represents a paramount driver for the in-vitro screening tests market. The increasing number of new cases, particularly among younger individuals, highlights a pressing public health demand for accessible and accurate diagnostic tools. This growing disease burden necessitates expanded screening to enable early detection, which is vital for enhancing patient survival and reducing mortality. According to the American Cancer Society, in January 2024, their annual report, "Cancer Statistics, 2024", indicated that colorectal cancer became the leading cause of cancer death in men and the second in women under 50 years old. This escalating incidence directly stimulates demand for improved in-vitro screening methods.

Key Market Challenges

Variable reimbursement policies and the high costs associated with advanced diagnostic technologies present a significant impediment to the expansion of the global in-vitro colorectal cancer screening tests market. These financial barriers restrict patient access to advanced screening options across diverse healthcare systems, particularly when insurance coverage is inconsistent or requires substantial out-of-pocket payments. This directly leads to lower adoption rates, as both healthcare providers and individuals may prioritize more affordable or covered alternatives, even if they are less comprehensive.

Key Market Trends

The growing integration of personalized medicine approaches is a significant trend in colorectal cancer screening, enabling tailored strategies based on individual genetic profiles and risk factors. This facilitates targeted early detection through specific biomarkers. According to the American Cancer Society, in January 2024, their "Cancer Statistics, 2024" report indicated nearly 3% of individuals under 50 diagnosed with colorectal cancer attributed their condition to family history or genetic factors, highlighting the need for individualized screening. Guardant Health, Inc.'s November 2025 report in Current Medical Research and Opinion exemplified this, noting its Shield blood-based screening test achieved 95% patient adherence, showcasing improved compliance with precision diagnostics.

Key Market Players

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Eiken Chemical Co., Ltd.
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quest Diagnostics Incorporated
  • Merck KGaA
  • Kyowa Kirin Co., Ltd.
  • Randox Laboratories Ltd.
  • R-Biopharm AG

Report Scope:

In this report, the Global In-vitro Colorectal Cancer Screening Tests Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In-vitro Colorectal Cancer Screening Tests Market, By Test Type:

  • Fecal Occult Blood Tests
  • Biomarker tests
  • CRC DNA Screening Tests

In-vitro Colorectal Cancer Screening Tests Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In-vitro Colorectal Cancer Screening Tests Market.

Available Customizations:

Global In-vitro Colorectal Cancer Screening Tests Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Fecal Occult Blood Tests, Biomarker tests, CRC DNA Screening Tests)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
    • 6.3.2. Canada In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
    • 6.3.3. Mexico In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type

7. Europe In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
    • 7.3.2. France In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
    • 7.3.3. United Kingdom In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
    • 7.3.4. Italy In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
    • 7.3.5. Spain In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type

8. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
    • 8.3.2. India In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
    • 8.3.3. Japan In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
    • 8.3.4. South Korea In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
    • 8.3.5. Australia In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type

9. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
    • 9.3.2. UAE In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
    • 9.3.3. South Africa In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type

10. South America In-vitro Colorectal Cancer Screening Tests Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
    • 10.3.2. Colombia In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
    • 10.3.3. Argentina In-vitro Colorectal Cancer Screening Tests Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global In-vitro Colorectal Cancer Screening Tests Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Beckman Coulter, Inc.
  • 15.3. Eiken Chemical Co., Ltd.
  • 15.4. Sysmex Corporation
  • 15.5. Siemens Healthineers AG
  • 15.6. Quest Diagnostics Incorporated
  • 15.7. Merck KGaA
  • 15.8. Kyowa Kirin Co., Ltd.
  • 15.9. Randox Laboratories Ltd.
  • 15.10. R-Biopharm AG

16. Strategic Recommendations

17. About Us & Disclaimer